文献速递物质与行为成瘾

物质使用障碍中肠道微生物组机制的临床与临床前证据

Clinical and Preclinical Evidence for Gut Microbiome Mechanisms in Substance Use Disorders.
PubMed 文献 · Biol Psychiatry · 2023-08-10

物质使用障碍是难治性神经精神疾病,现有治疗有限。综述汇总临床与临床前研究,提示肠道微生物组可调节脑与行为,并讨论其神经生物学机制及从实验到临床的转化方向。

要点

  • 肠道微生物组在临床前与临床研究中可调节脑与行为。
  • 微生物组发现尚未转化为物质使用障碍的临床实践。
  • 需推进从实验到临床的转化研究。

核心结论

  • 肠道微生物组在物质使用障碍的临床前与临床研究中起重要作用,但尚未转化为临床实践。

研究设计与样本

  • 综述汇总物质使用障碍领域微生物组-脑研究的临床与临床前证据。

主要发现

  • 临床前与临床研究显示肠道微生物组可调节脑与行为。
  • 物质使用障碍共享升级失控、负性后果下持续使用及缓解复发模式。

临床怎么用

  • 当前证据尚不足以将微生物组干预用于物质使用障碍临床实践。

局限性

  • 微生物组发现尚未转化为临床实践。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Substance use disorders are a set of recalcitrant neuropsychiatric conditions that cause tremendous morbidity and mortality and are among the leading causes of loss of disability-adjusted life years worldwide. While each specific substance use disorder is driven by problematic use of a different substance, they all share a similar pattern of escalating and out-of-control substance use, continued use despite negative consequences, and a remitting/relapsing pattern over time. Despite significant advances in our understanding of the neurobiology of these conditions, current treatment options remain few and are ineffective for too many individuals. In recent years, there has been a rapidly growing body of literature demonstrating that the resident population of microbes in the gastrointestinal tract, collectively called the gut microbiome, plays an important role in modulating brain and behavior in preclinical and clinical studies of psychiatric disease. While these findings have not yet been translated into clinical practice, this remains an important and exciting avenue for translational research. In this review, we highlight the current state of microbiome-brain research within the substance use field with a focus on both clinical and preclinical studies. We also discuss potential neurobiological mechanisms underlying microbiome effects on models of substance use disorder and propose future directions to bring these findings from bench to bedside.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Hofford RS, Kiraly DD. Clinical and Preclinical Evidence for Gut Microbiome Mechanisms in Substance Use Disorders. Biol Psychiatry. 2023. PMID: 37573004. doi:10.1016/j.biopsych.2023.08.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。